for females ages 15 years and up (full criteria)
Healthy Volunteers
healthy people welcome
at Oakland, California and other locations
study started
completion around
Principal Investigator
by Daniel Grossman, MD



This study aims to evaluate the feasibility, acceptability, and effectiveness of dispensing mifepristone via a mail-order pharmacy. The investigators will recruit patients at up to 10 primary care and internal medicines sites not currently providing abortion services around the country, as well as abortion clinic sites. Patients will go through routine in clinic visits to determine eligibility and then will receive the medications in the mail at their preferred address. The investigators will survey patients 3 and 14 days after the initial clinic visit and interview providers at the end of the study.

Official Title

Feasibility and Acceptability of Dispensing Mifepristone Via Mail Order Pharmacy


This is a prospective cohort study of patients obtaining medication abortion via mifepristone dispensed from an online mail order pharmacy. After an initial pilot test with 25 patients, the investigators will identify 10 clinics to participate in the study. The study team will train primary care providers not currently providing abortion to provide medication abortion with the medications dispensed via mail order pharmacy. The investigators aim to recruit up to 650 patients for this study across all the sites. Patients will come in for an initial consult visit at the study site and then receive their medications at a preferred address within 3 days of the initial visit. Study participants will fill out surveys about their experience and feedback about the acceptability of the process; this will occur at 3 and 14 days after the initial recruitment visit. The investigators will also collect clinic data from patients and clinic sites to track clinical outcomes. And the investigators will interview providers at the end of the study to better understand their experiences prescribing mifepristone via mail-order.


Abortion Early, Pregnancy Related, Mifepristone


You can join if…

Open to females ages 15 years and up

  • Women seeking medication abortion through 63 days gestation
  • Eligible for MifeprexⓇ at a study site
  • English or Spanish speaking
  • Willing and able to participate in the study, including willing and able to receive medications at home or other preferred address within 3 days of initial medication abortion visit

You CAN'T join if...

  • Not pregnant
  • Not seeking medication abortion
  • under the age of 15
  • Over 63 days gestation
  • Contraindicated for medication abortion


  • Children's Hospital Oakland
    Oakland California 94609 United States
  • Highland Hospital
    Oakland California 94602 United States

Lead Scientist at UCSF

  • Daniel Grossman, MD
    Professor, Ob/Gyn, Reproductive Sciences, School of Medicine. Authored (or co-authored) 97 research publications


in progress, not accepting new patients
Start Date
Completion Date
Daniel Grossman, MD
Phase 4 research study
Study Type
About 538 people participating
Last Updated